Skip to main content
. Author manuscript; available in PMC: 2006 May 30.
Published in final edited form as: J Am Coll Surg. 2004 May;198(5):685–696. doi: 10.1016/j.jamcollsurg.2004.01.025

Table 1.

Four Sequential Questions that Have Hallmarked Progress in the Development of Human Cancer Immunotherapy

1. Is it possible? (Can immune stimulation cause the regression of established human cancers?)
2. What are the antigens involved?
3. Can antitumor T-cells be generated in vivo by antigen immunization?
4. What mechanisms limit cancer regression despite the in vivo generation of antitumor T-cells?